Institute of Physiology, Autonomous University of Puebla, México.
Curr Neuropharmacol. 2010 Mar;8(1):26-40. doi: 10.2174/157015910790909511.
This work reviews the neuropharmacology of the vestibular system, with an emphasis on the mechanism of action of drugs used in the treatment of vestibular disorders. Otolaryngologists are confronted with a rapidly changing field in which advances in the knowledge of ionic channel function and synaptic transmission mechanisms have led to the development of new scientific models for the understanding of vestibular dysfunction and its management. In particular, there have been recent advances in our knowledge of the fundamental mechanisms of vestibular system function and drug mechanisms of action. In this work, drugs acting on vestibular system have been grouped into two main categories according to their primary mechanisms of action: those with effects on neurotransmitters and neuromodulator receptors and those that act on voltage-gated ion channels. Particular attention is given in this review to drugs that may provide additional insight into the pathophysiology of vestibular diseases. A critical review of the pharmacology and highlights of the major advances are discussed in each case.
这项工作回顾了前庭系统的神经药理学,重点介绍了用于治疗前庭障碍的药物的作用机制。耳鼻喉科医生面临着一个快速变化的领域,其中离子通道功能和突触传递机制知识的进步导致了新的科学模型的发展,用于理解前庭功能障碍及其管理。特别是,我们对前庭系统功能的基本机制和药物作用机制的认识有了最近的进展。在这项工作中,根据其主要作用机制,作用于前庭系统的药物被分为两类:作用于神经递质和神经调质受体的药物和作用于电压门控离子通道的药物。在本综述中特别关注可能为前庭疾病的病理生理学提供更多见解的药物。在每种情况下,都对药理学进行了批判性回顾,并重点介绍了主要进展。